Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00668434 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Oral Prednisone in Improving Physical Functioning and Decreasing Pain in People With Sciatica
A Phase 2 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 2
- Development phase
- 269
- Enrollment target
NCT00668434: Completed Phase 2 study, sponsored by Kaiser Permanente.
NCT00668434 is a Phase 2 study that has completed, run by Kaiser Permanente. The registered enrollment target is 269 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (102% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00668434, a Phase 2 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 269 participants
- Enrollment target
Study Summary
Sciatica is a condition that causes a sharp, burning pain in the back, buttock, and leg. The condition is caused by injury to or compression of the sciatic nerve, which is located in the back of the leg. This study will determine the effectiveness of the steroid prednisone in decreasing pain and improving function in people with sciatica.
Primary Outcome
The Oswestry Disability Index, v2 is a back-pain-specific measure of disability and functional status. It is measured on a 0-to-100 scale, with higher numbers indicating greater disability.
Interventions
- DRUG Placebo
- DRUG Prednisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 269 participants |
| Start Date | 2008-11 |
| Est. Completion | 2013-09 |
| Phase | Phase 2 |
What the finished NCT00668434 record still lists
NCT00668434 is an interventional study that assigns participants to a tested intervention. The registered 269 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (102% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00668434 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00668434 about?
NCT00668434 is a clinical study titled "Effectiveness of Oral Prednisone in Improving Physical Functioning and Decreasing Pain in People With Sciatica". Sciatica is a condition that causes a sharp, burning pain in the back, buttock, and leg. The condition is caused by injury to or compression of the sciatic nerve, which is located in the back of the leg. This study will determine the effectiveness of the steroid prednisone in decreasing pain and imp...
What is the current status of trial NCT00668434?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 269 participants. The study started on 2008-11. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00668434?
The interventions under investigation include: Placebo (DRUG), Prednisone (DRUG).
Who is sponsoring clinical trial NCT00668434?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00668434's enrollment target sits among peer trials
269 208th of 2000 higher than 1,793 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04802291 · 269 participants · NA
HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity
- NCT06500455 · 269 participants · Phase 3
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
- NCT06630676 · 269 participants · NA
The Ability of Chronic Pain Patients to Self-diagnose Their Chief Source of Low Back Pain
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia